Loading insider details...
Beta
Latest Form 4 (Jun 18, 2026): Grant/Award of 233,957 GNLX shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jun 18, 2026 | GENELUX Corp (GNLX) | Grant/Award | 233,957 | n/a |
| Jul 2, 2025 | GENELUX Corp (GNLX) | Grant/Award | 270,000 | n/a |
| Mar 23, 2024 | Rani Therapeutics Holdings, Inc. (RANI) | Grant/Award | 323,500 | n/a |
| Dec 19, 2023 | Rani Therapeutics Holdings, Inc. (RANI) | Disposition to Issuer | 171,500 | n/a |
| Mar 30, 2023 | Rani Therapeutics Holdings, Inc. (RANI) | Grant/Award | 139,000 | n/a |
| Mar 24, 2023 | Rani Therapeutics Holdings, Inc. (RANI) | Tax Withholding | 2,498 | $14.9K |
| Mar 25, 2022 | Rani Therapeutics Holdings, Inc. (RANI) | Grant/Award | 24,500 | n/a |